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Standard  methods  for  assessing  the  thermal  stability  of  viruses  can  be  time  consuming  and  rather  qual-
itative  yet  such  data  is a necessary  requisite  for  vaccine  formulation.  In  this  study  a  novel  plate-based
thermal  scanning  assay  for  virus  particle  stability  has been  developed  (PaSTRy:  Particle  Stability  Ther-vailable online 26 June 2012
eywords:
igh-throughput
irus stability
mal  Release  Assay).  Two  environment-sensitive  ﬂuorescent  dyes,  with  non-overlapping  emission  spectra
and  different  afﬁnities,  are  used  to  accrue  simultaneously  independent  data  for  the overall  stability  of
the  virus  capsid,  as judged  by the  exposure  of  the  genome,  and  for capsid  protein  stability  according  to
the  exposure  of  hydrophobic  side  chains  which  are  normally  buried.  This  offers  a  fast  and  efﬁcient  high-
throughput  method  to  optimise  vaccine  formulation  and  to  investigate  the  processes  of  virus uncoating.accine formulation
Determination of the stability of virus particles is critical to the
evelopment of vaccines which must remain stable for transport
nd storage. This issue is especially important in the developing
orld where longer transport times and the absence of an estab-
ished cold chain can hamper vaccination programmes. Current
ethods for assaying particle stability use comparative infectiv-
ty with respect to standards to determine the number of infective
irions per unit volume (WHO, 2006).
Thermal scanning is a well-established method for the assess-
ent of protein stability, in which the protein sample is slowly
eated and its state monitored. Fourier-transform infrared spec-
roscopy (FTIR (Cooper and Knutson, 1995; Niesen et al., 2008)) and
ircular dichroism (CD (Benjwal et al., 2006)) have both been used
o follow the loss of protein secondary structure as the temperature
f the sample is increased, however calorimetry (Brandts and Lin,
990) and light-scattering (Kurganov, 2002), are more popular due
o the ready availability of these instruments.
For soluble proteins the so-called Thermoﬂuor (also known
s differential scanning ﬂuorimetry, DSF, or thermal shift assay)
Pantoliano et al., 2000) has proven useful for identifying con-
itions which change the stability of the protein (Niesen et al.,
008) or for ﬁnding more stable homologues and mutants (Lavinder
t al., 2009). Thermoﬂuor uses an environment-sensitive ﬂuores-
ent dye to monitor the exposure of the hydrophobic core of the
rotein to solvent and hence protein unfolding, and has become
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popular due to the ease of implementation on conventional quan-
titative PCR instruments (qPCR) combined with ﬂuorescent dyes
originally developed as gel stains, especially SYPRO orange. The
use of standard format 96-well plates and relatively small amounts
of material make this an attractive method, which has been suc-
cessfully deployed with proteins for several years by ourselves and
others (Ericsson et al., 2006; Geerlof et al., 2006; Sainsbury et al.,
2008).
Many viruses comprise an effectively sealed protein shell har-
bouring the viral genome. It might be expected therefore that the
loss of capsid integrity would proceed, perhaps via conformational
changes, to the point where the protein shell either undergoes com-
plete dissolution releasing the genome, or reconﬁgures to such an
extent that the genome either escapes or is rendered accessible
to dye. In either case, although the protein subunits are unlikely
to unfold they may  well expose hydrophobic regions concealed in
the native capsid. Whilst changes in virus capsid protein associ-
ation might therefore be monitored using a ﬂuorescent dye such
as SYPRO orange, a dye sensitive to the presence of nucleic acid
would allow the accessibility of nucleic acid to be directly moni-
tored. The use of two dyes simultaneously would provide a picture
of the changes in the protein components, via a series of melting
temperatures, Tms, alongside the temperature at which nucleic acid
is released or exposed, TR, (calculated in the same way as Tm). Such
a nucleic acid dye must be sensitive over a broad range of temper-
Open access under CC BY license.ature and physical and chemical conditions, have excitation and
emission spectra compatible with the instrumentation available,
and, critically, be sufﬁciently large so as not to prematurely pene-
trate the mature viral capsid through pores or “thermal breathing”,
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hereby obscuring any change in ﬂuorescence upon capsid opening
Tuthill et al., 2009).
This  study sought to devise a thermoﬂuor-type assay to accu-
ately assess the stability of viral capsids. Such an assay could be
seful for improving vaccine stability, and as a general tool to exam-
ne the dynamics of viral uncoating.
Equine rhinitis A virus (ERAV) was produced and puriﬁed as
reviously described (Tuthill et al., 2009). Brieﬂy, infected Ohio
eLa cells were lysed by freeze–thawing at the peak of virus
rowth. After centrifugation to remove cell debris virus particles
ere precipitated with ammonium sulphate and pelleted through
 30% sucrose cushion before separation by ultracentrifugation in a
5–45% sucrose gradient. The virus was located by measuring the
bsorbance at 260 nm of the fractionated gradient.
The  preparation used for the initial proof of principle experi-
ent contained approximately 30% sucrose and contained ERAV
t a concentration of approximately 0.04 mg/mL. The investigation
f the pH-dependence of particle and capsid protein stability used
aterial from which the sucrose had been removed and which had
een concentrated to approximately 0.15 mg/mL  in 50 mM HEPES
H 7.3, 50 mM NaCl.
The type 1 Mahoney strain Polio virus (PV) was  produced and
uriﬁed as previously described (Tuthill et al., 2006). Brieﬂy, PV
as grown in HeLa cells maintained in suspension culture. The cells
ere harvested by centrifugation and were subjected to two  cycles
f freeze–thaw to release the virus before removal of cell debris by
ow speed centrifugation. The virus was puriﬁed by ultracentrifu-
ation in a CsCl density gradient and the fractions containing the
irus particles pooled and concentrated.
Bovine enterovirus type 2 (BEV2) was produced and puriﬁed as
escribed previously for BEV type 1 (Smyth et al., 1993). Brieﬂy,
HK 21 cell monolayers were infected with BEV2 and the cells and
upernatant harvested at maximum cpe. After freeze–thawing the
ebris was removed by centrifugation and the supernatant made
0% saturated ammonium sulphate to precipitate virus. The resus-
ended virus was pelleted through a 30% sucrose cushion and
nally puriﬁed by ultracentrifugation through a 15–45% sucrose
radient.
For the PaSTRy assay, 50 L volume reactions were set up per
ell. Typically a small volume of concentrated sample provided
–2 g virus per experiment although if the virus concentration
as low then a larger volume of sample was required in order to
rovide a minimum of 1 g.
Fluorescent dyes were obtained from Molecular Probes (Life
echologies, Paisley, UK); 5000× stocks of both SYPRO orange
product S-6650) and SYPRO red (S-6653), 5 mM stock of SYTO9
S-34854) and 10,000× of SYBR green II (S-7564), all supplied in
imethylsulphoxide (DMSO). Working stocks of 50× SYPRO orange
nd SYPRO red, 100× SYBR green II, and 50 M SYTO9 were pro-
uced freshly for each experiment by dilution in milliQ-grade
ater. The dyes were used at ﬁnal concentrations of 3× SYPRO
range and SYPRO red, 10× SYBR green II and 5 M,  SYTO9, by
iluting the working stocks into the ﬁnal reaction, or in the case of
ultiple parallel experiments, by preparation of mastermix solu-
ions containing dyes, buffer and virus sample.
The remainder of the 50 L reaction volume was made up with
uffer, 10 mM HEPES pH 8.0, 200 mM NaCl. By using a large vol-
me of well-buffered screening solution with a small volume of
ample it is possible to readily screen a wide range of condi-
ions while diluting the effect of any constituent of the sample
uffer.
In order to screen the pH-dependence of ERAV the SPG bufferixture (Molecular Dimensions, Newmarket, UK) consisting of suc-
inate, phosphate and glycine, (Newman, 2004)) was used at 0.1 M
cross a pH range of 4.0–9.5 in 0.5 pH unit steps with 0.1 M NaCl in
ll wells. This buffer mixture contains all ion species at all points inl Methods 185 (2012) 166– 170 167
the  pH range and so any stabilisation effect of speciﬁc ions could
be excluded from the analysis.
Typically  a dual-dye reaction would contain the following:
Virus sample (1 mg/mL) 1 Total 1 g
SYPRO red (50×) 3 3× ﬁnal
SYTO9  (50 M)  5 5  M ﬁnal
Buffer 41
Total 50 L
For the experiments described below we  used two  different
machines, the Opticon2 (Bio-rad, Hemel Hempstead, UK) and
the MX3005p (Agilent, Edinburgh, UK). Reactions were set up in
96-well PCR plates (low proﬁle skirted plates AB-1000/w, Thermo,
for the BioRad instrument; semi-skirted plates, product 401334,
Agilent, for the Agilent instrument), mixed by pipetting, and
then centrifuged at 2000 × g to remove any bubbles. The plates
were then sealed using optically clear foils (BioRad Microseal B,
MSB-1001).
The BioRad Opticon2 qPCR machine uses an array of LEDs for
excitation in the 470–505 nm range. Emission is detected on two
channels: 523–543 nm and 540–700 nm.  Both SYPRO orange and
SYTO9 (or SYBR green) produced a stronger signal in the second,
broader, channel so this was  used for detection of all dyes. This
instrument therefore can only be used for experiments with one
dye per well. Thermal control is provided by the Peltier unit of a
MJ Research DNA Engine which can achieve temperatures below
ambient.
The experiments were ramped from 4 to 99 ◦C, taking a ﬂuo-
rescence reading every 0.5 ◦C after holding for 10 s, each such run
taking approximately one hour to complete. Particular attention
was paid to ensure that heating of the sample was not excessive
while the lid of the instrument was pre-heated.
The temperatures (TR, Tm) of the transitions for melting curves
were calculated from the inﬂection point (dI/dT) of the ﬂuorescence
intensity (I) as a function of temperature (T). When necessary, noisy
data were smoothed to aid the identiﬁcation of the dI/dT peak and
hence assign TR or Tm.
The  MX3005 qPCR machine uses a quartz tungsten halogen lamp
in combination with one of ﬁve selectable bandpass ﬁlters for exci-
tation; and a single scanning photomultiplier tube with one of ﬁve
bandpass ﬁlters for ﬂuorescence detection. Both the excitation and
emission ﬁlters, bandwidth ∼10 nm,  can be speciﬁed as required
and are independently selectable in order to allow mismatching.
The excitation (ex) and emission (em) bandpass ﬁlters used for the
dyes were as follows: SYPRO orange, ex: 492 nm,  em:  585 nm (∼20%
stronger than ex: 492 nm,  em:  610 nm); SYPRO red, ex: 585 nm,  em:
665 nm (∼30% stronger than ex: 535 nm, em:  665 nm); SYTO9, ex:
492 nm,  em:  517 nm.  Thermal control for this instrument is also
provided by a Peltier unit which in this case can only operate from
25 to 100 ◦C limiting the low temperature data that can be gathered.
The experiments were ramped from 25 to 99 ◦C recording in
triplicate ﬂuorescence readings for each of the ﬁlter combinations
speciﬁed every 1 ◦C, taking approximately one hour to complete.
Initial investigations indicated that the RNA-sensitive dyes SYBR
green II and SYTO9 were both suitable (data not shown). Proof-
of-principle experiments with these dyes used two picornaviruses
which show different capsid alterations during the process of cell
entry and uncoating; equine rhinitis A virus (ERAV), an aphthovirus
often used as a surrogate for foot-and-mouth disease virus, dis-
sociates into pentameric units after release of the RNA (Tuthill
et al., 2009), and the enterovirus poliovirus type I, which under-
goes a conformational transition to release the RNA genome from
an expanded particle (Hogle, 2002). Parallel experiments contain-
ing one dye each were set up to monitor both the protein unfolding,
via Tm, and the RNA release, via TR, from the virus capsid (Fig. 1a).
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Fig. 1. Monitoring protein unfolding (broken-lines) and RNA release (solid lines) using SYPRO orange and SYBR green II (SYTO9 was identical). (a) ERAV (TR 55 ◦C, Tm 69 ◦C
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tabilised by sucrose); (b) poliovirus, TR 45 ◦C, major Tm 80 ◦C, note second Tm coinci
enome and unfolding of capsid proteins vary independently with pH. (a) and (c) u
or ERAV the temperature of release of nucleic acid, TR, and the
rotein melting temperature, Tm, were found to be quite distinct,
5 ◦C and 69 ◦C respectively (Fig. 1a) for 1 g of virus (Tm rose to
4 ◦C for 2 g virus in the presence of greater amounts of sucrose).
o Tm was observed coincident with the release of RNA, indicat-
ng that few hydrophobic residues were exposed to solvent upon
apsid opening. This ﬁnding is in line with the largely polar nature
f the interface between pentamers observed in the crystal struc-
ure (Tuthill et al., 2009). For poliovirus (Fig. 1b) the picture was
roadly similar to ERAV, with a lower TR of 45 ◦C and a major Tm at
1 ◦C, however there was another less-pronounced but distinct Tm
t the same temperature as TR reﬂecting the conformational change
ssociated with capsid expansion and exposure of viral RNA. The pH
tability of the ERAV capsid and the capsid proteins was also inves-
igated using a broad-range buffer (Newman, 2004). The results
Fig. 1c) conﬁrm that protein unfolding and RNA release data are
istinct properties. The stability of the capsid is much reduced in an
cidic environment, TR falls below body temperature at less than pH
, consistent with acid-induced uncoating (and inactivation (Tuthill but not the capsid. Controls: sucrose, free-RNA and non-viral protein Rac1 (also
ith TR. Control: virus uncoated by pre-heating (10 min, 60 ◦C). (c) Exposure of ERAV
ioRad Opticon2 and (b) an Agilent MX3005p.
et  al., 2009)). In contrast the capsid proteins have peak stability ∼pH
6 and are stable over a broader pH range.
To increase sensitivity and monitor both TR and Tm simulta-
neously a “dual-dye” protocol was developed. This requires that
the emission spectra of the dyes are sufﬁciently different to avoid
cross-talk and also requires a qPCR machine with appropriate band
pass ﬁlters (e.g. Agilent MX3005p). By substituting the dye SYPRO
orange with the similar protein dye SYPRO red the emission spec-
trum could be monitored near its peak (ex: 585 nm, em:  665 nm). At
this wavelength the ﬂuorescence from nucleic acid-bound SYTO9
is undetectable (a small amount of cross-talk is observed for SYBR
green II). Similarly by monitoring SYTO9 at 517 nm near its emis-
sion peak there is no cross-talk from the ﬂuorescence of SYPRO red
(data not shown). Dye concentration is critical to obtaining a good
signal, particularly for the protein-sensitive dyes which exhibit col-
lisional quenching at ﬁnal concentrations greater than ∼4× (data
not shown). The RNA-dependent dyes produce a ∼7-fold greater
ﬂuorescence signal than the protein-dependent dyes and therefore
the release of nucleic acid could potentially be observed using an
T.S. Walter et al. / Journal of Virologica
Fig. 2. Analysis of mature virus particles of BEV2 with SYPRO red (broken-lines) and
SYTO9 (solid lines) performed in dual-dye experiments. (a) Capsid proteins show
several Tm (45, 58, 81 ◦C), one associated with genome exposure (TR 58 ◦C). (b) Anal-
ysis  of protocols to capture uncoating intermediates using pre-heating for 0 to 5 min
at 56 ◦C before cooling and performing the assay. With longer incubation a greater
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ent mechanisms of genome release. The present protocol allows 96
conditions to be screened in as little as an hour and could be used
to fast-track vaccine formulation tests compared to current tech-
niques. In this study it was observed that the method will tolerate aroportion  of virions uncoated, as indicated by increased initial ﬂuorescence and
oss of the TR (58 ◦C) and coincident protein Tm. Both experiments used an Agilent
X3005p.
rder of magnitude less virus. Nevertheless, in many cases gather-
ng complementary data simultaneously for both RNA release and
rotein rearrangement is extremely valuable.
The effectiveness of this dual-dye system is shown in Fig. 2a,
here the stability of particles both containing and lacking RNA
or a second enterovirus, BEV2 (Fry, E., Ren, J., Walter, T.S., Row-
ands, D., Stuart, D.I., unpublished data) is investigated. In addition
o the transition associated with the global unfolding of the capsid
roteins (Tm of ∼80 ◦C), BEV2 showed, as for poliovirus, a second
rotein melting transition (Tm of 58 ◦C) coincident with the release
f RNA (TR of 58 ◦C). BEV2 is clearly more stable than poliovirus
TR being elevated by 13 ◦C). This demonstrates the ability to
eliably monitor this transition via the exposure of hydropho-
ic residues, and is consistent with the previous observations of
onformational changes in poliovirus upon heating (Hogle, 2002).
nterestingly, for BEV2, there is another transition (Tm of 46 ◦C),
hich remains uncharacterised, before the genome is released. The
ual-dye experiment was used to evaluate different pre-heating
rotocols, providing a quick and straightforward measure of the
xtent of the modiﬁcation on the population of virus particles
Fig. 2b).
How robust is the method in the face of the use of dif-
erent excipients in the formulation? To address this we  have
erformed a full spectral analysis, with scans taken from 0.5 mL
amples in a quartz cuvette by a Perkin-Elmer (Waltham,
SA) Luminescence Spectrometer LS50B using 3 nm slits forl Methods 185 (2012) 166– 170 169
both  excitation and emission with a scan speed of 50 nm/min.
Yeast RNA extract (8 g/mL, Sigma–Aldrich, Poole UK) and
the detergent dodecyl-beta-maltoside (DDM,1.5 mM,  ∼10 × CMC)
(Anatrace, High Wycombe, UK) were used to enhance the ﬂuores-
cence of SYTO9 and SYPROred respectively. All samples contained
0.1 M succinate–phosphate–glycine buffer (SPG, Molecular Dimen-
sions Newmarket, UK; Newman, 2004). We  analysed not only our
original formulation but a wide range of alternatives. We  found
that both dyes work across a pH range from 4 to 10, showing no
spectral disturbance (although there is marked intensity fall off for
SYTO9 at the extremes, data not shown). Thus the method can be
used across a broad pH range. We also looked at the effect of high
salt (4 M NaCl), sucrose (56%) and PEG3350 (40%) concentrations.
In no case was  there a signiﬁcant change in the spectral properties
or sufﬁcient loss of efﬁciency to compromise the method.
Finally we have investigated how the results correlate with
conventional infectivity-based assays of thermal stability. We  per-
formed experiments with BEV2 and poliovirus. Infected cell culture
supernatants were adjusted to approximately equivalent titres
by at least ten-fold dilution into cell culture medium (DMEM
supplemented with 1% serum, 20 mM HEPES and penicillin and
streptomycin at standard concentrations). Samples were incubated
at elevated temperatures and times (see Fig. 3) and infectivity
titrated by plaque assay. Brieﬂy, conﬂuent monolayers were inocu-
lated with ten-fold serial dilutions of samples and overlaid with
medium (as above) containing 0.6% agarose. Monolayers were
ﬁxed and stained two days post-infection with 10% ethanol, 3.7%
formaldehyde, 1 mg/mL  methylene blue. Plaques were counted and
titres expressed as pfu/mL. The results are shown in Fig. 3. We
would expect TR to correspond to the temperature at which the
virus becomes inactivated and this temperature is 58 ◦C and 45 ◦C
for BEV2 and poliovirus respectively. In line with this BEV shows lit-
tle loss of infectivity at either 40 ◦C or 45 ◦C whilst poliovirus shows
the expected dramatic loss of infectivity at 45 ◦C.
In summary, a technique has been devised, termed PaSTRy
(protocols available from the authors), using thermal-scanning
with ﬂuorescent dyes to characterise virus capsid stability and has
been shown to be effective for picornaviruses possessing differ-Fig. 3. Infectivity of heat-treated particles of BEV2 (labelled BEV) and poliovirus
(labelled  PV), as estimated by plaque assay after incubation at two temperatures
(40 ◦C and 45 ◦C) and for times of 0, 15 and 60 min.
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ange of excipients in the formulation, but the level of virus purity
equired has not been investigated systematically. In addition the
emperature at which the RNA is made accessible (TR) appears to
e a good surrogate for the temperature at which virus inactiva-
ion occurs, as measured by infectivity assay. It may  be necessary
o use larger or conjugated nucleic-acid sensitive dyes with viruses
hat have enlarged capsid pores. Nonetheless, this technique should
ave broad applicability beyond the investigation of the dynamics
f virus uncoating and genome release, to the general characterisa-
ion of protein-nucleic acid complexes, as well as facilitating sample
ormulation for the production of more stable vaccines.
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